Compare, Analyse GSK Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
GSK PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,595384-   
Low Rs1,253277-   
Sales per share (Unadj.) Rs184.7114.1-  
Earnings per share (Unadj.) Rs26.3-28.7-  
Cash flow per share (Unadj.) Rs29.2-23.8-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.389.5-  
Shares outstanding (eoy) m169.40168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.12.9 453.7%   
Avg P/E ratio x92.2-11.5 -802.9%  
P/CF ratio (eoy) x83.1-13.9 -599.9%  
Price / Book Value ratio x19.23.7 520.6%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,62655,714 737.0%   
No. of employees `0005.04.3 115.5%   
Total wages/salary Rs m5,3723,497 153.6%   
Avg. sales/employee Rs Th6,306.74,485.3 140.6%   
Avg. wages/employee Rs Th1,083.1814.5 133.0%   
Avg. net profit/employee Rs Th898.0-1,130.2 -79.5%   
INCOME DATA
Net Sales Rs m31,28119,256 162.5%  
Other income Rs m1,023135 758.8%   
Total revenues Rs m32,30419,390 166.6%   
Gross profit Rs m6,009-3,337 -180.1%  
Depreciation Rs m486831 58.5%   
Interest Rs m6522 1.2%   
Profit before tax Rs m6,540-4,555 -143.6%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,373285 833.8%   
Profit after tax Rs m4,454-4,852 -91.8%  
Gross profit margin %19.2-17.3 -110.8%  
Effective tax rate %36.3-6.2 -580.7%   
Net profit margin %14.2-25.2 -56.5%  
BALANCE SHEET DATA
Current assets Rs m20,06114,103 142.2%   
Current liabilities Rs m14,5437,935 183.3%   
Net working cap to sales %17.632.0 55.1%  
Current ratio x1.41.8 77.6%  
Inventory Days Days57111 51.2%  
Debtors Days Days14124 11.3%  
Net fixed assets Rs m14,3438,221 174.5%   
Share capital Rs m1,69489 1,894.8%   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,39815,114 141.6%   
Long term debt Rs m25,311 0.0%   
Total assets Rs m39,11328,551 137.0%  
Interest coverage x1,091.0-7.7 -14,109.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.7 118.6%   
Return on assets %11.4-15.2 -75.2%  
Return on equity %20.8-32.1 -64.8%  
Return on capital %31.9-19.8 -161.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,9941,644 243.0%  
From Investments Rs m-1,433-505 284.0%  
From Financial Activity Rs m-3,5844,820 -74.3%  
Net Cashflow Rs m-1,0235,959 -17.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.29 Rs / ZAR

Compare GSK PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: ELDER PHARMA  ALEMBIC PHARMA  VENUS REMEDIES  CIPLA  SANOFI INDIA  



Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; JSW Steel and ICICI Bank Among Top Nifty Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Related Views On News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

GSK PHARMA SHARE PRICE


Apr 22, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA 5-YR ANALYSIS

COMPARE GSK PHARMA WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS